Legal News

Life Sciences weekly highlights—8 October 2020

Life Sciences weekly highlights—8 October 2020
Published on: 08 October 2020
Published by: LexisPSL
  • Life Sciences weekly highlights—8 October 2020
  • In this issue:
  • Advertising of medicines
  • A v Daniel B judgment
  • Coronavirus (COVID-19)
  • Is the aviation insurance market ready for a coronavirus (COVID-19) vaccine?
  • Coronavirus (COVID-19)—MHRA updates Clinical Trial guidance
  • EMA commences rolling review of coronavirus (COVID-19) vaccine
  • EMA launches rolling review of a coronavirus (COVID-19) mRNA vaccine
  • FDA issues guidance on ‘emergency use authorizations’ for coronavirus (COVID-19) vaccines
  • More...

Article summary

This week’s edition of Life Sciences weekly highlights includes a Court of Justice judgment deciding on whether one Member State may restrict the online advertising methods of another Member State, the latest coronavirus (COVID-19) developments, including an interesting look at the aviation regulatory issues distributors may need to consider before contracting mass distribution of a vaccine and the European Medicines Agency’s (EMA) start of rolling reviews of two vaccines, a report finding the UK leads Europe in early clinical trials but needs to improve restarting its non-COVID trial progress while new adaptive licensing pathways to ‘transform’ UK clinical trials were proposed by the Health Research Authority, new biosimilars guidance drafted by the Medicines and Healthcare products Regulatory Agency (MHRA) and the latest Brexit developments, including transition guidance for orphan medicinal products. or take a trial to read the full analysis.

Popular documents